Benefits of the Non-Steroidal Mineralocorticoid Receptor Antagonist Finerenone in Metabolic Syndrome-Related Heart Failure with Preserved Ejection Fraction

  1. Lima-Posada, I.
  2. Stephan, Y.
  3. Soulié, M.
  4. Palacios-Ramirez, R.
  5. Bonnard, B.
  6. Nicol, L.
  7. Kolkhof, P.
  8. Jaisser, F.
  9. Mulder, P.
Zeitschrift:
International Journal of Molecular Sciences

ISSN: 1422-0067,  1661-6596

Datum der Publikation: 2023

Ausgabe: 24

Nummer: 3

Art: Artikel

DOI: 10.3390/IJMS24032536 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus